NYSE:RE - Everest Re Group Stock Price, Forecast & News

Everest Re Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "RE."

Everest Re Group declared a quarterly dividend on Wednesday, February 26th. Investors of record on Wednesday, March 11th will be paid a dividend of $1.55 per share on Monday, March 30th. This represents a $6.20 dividend on an annualized basis and a yield of 2.27%. View Everest Re Group's Dividend History.

Everest Re Group Ltd (NYSE:RE) released its earnings results on Monday, February, 10th. The insurance provider reported $3.20 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.64 by $0.56. The insurance provider had revenue of $2.14 billion for the quarter, compared to analyst estimates of $2.13 billion. Everest Re Group had a net margin of 12.31% and a return on equity of 9.85%. During the same quarter in the prior year, the business earned ($5.89) EPS. View Everest Re Group's Earnings History.

Everest Re Group is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Everest Re Group.

8 equities research analysts have issued 1-year price objectives for Everest Re Group's shares. Their forecasts range from $250.00 to $325.00. On average, they anticipate Everest Re Group's share price to reach $279.75 in the next twelve months. This suggests a possible upside of 2.4% from the stock's current price. View Analyst Price Targets for Everest Re Group.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Everest Re Group in the last year. There are currently 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Everest Re Group.

Press coverage about RE stock has been trending somewhat negative recently, according to InfoTrie. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Everest Re Group earned a daily sentiment score of -1.2 on InfoTrie's scale. They also gave press coverage about the insurance provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Everest Re Group.

Everest Re Group saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 968,500 shares, an increase of 10.1% from the January 15th total of 879,400 shares. Based on an average trading volume of 243,000 shares, the short-interest ratio is currently 4.0 days. Currently, 2.4% of the company's stock are sold short. View Everest Re Group's Current Options Chain.

Some companies that are related to Everest Re Group include Alleghany (Y), Reinsurance Group of America (RGA), RenaissanceRe (RNR), Enstar Group (ESGR), Greenlight Capital Re (GLRE), Maiden (MHLD) and Partnerre (PRE.PH).

Based on aggregate information from My MarketBeat watchlists, some companies that other Everest Re Group investors own include iShares Nasdaq Biotechnology ETF (IBB), Adobe (ADBE), iShares PHLX Semiconductor ETF (SOXX), Bank of America (BAC), Lendingtree (TREE), UnitedHealth Group (UNH), Visa (V), Costco Wholesale (COST), Gilead Sciences (GILD) and NVIDIA (NVDA).

Everest Re Group's stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (5.22%), AQR Capital Management LLC (4.91%), Boston Partners (4.53%), Franklin Resources Inc. (3.57%), Alliancebernstein L.P. (3.21%) and LSV Asset Management (2.51%). Company insiders that own Everest Re Group stock include John A Weber, John P Doucette, Jonathan Zaffino, Meryl D Hartzband and Roger M Singer. View Institutional Ownership Trends for Everest Re Group.

RE stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Boston Partners, PGGM Investments, Scout Investments Inc., LSV Asset Management, Caisse DE Depot ET Placement DU Quebec, Panagora Asset Management Inc. and Donald Smith & CO. Inc.. Company insiders that have sold Everest Re Group company stock in the last year include John A Weber, John P Doucette, Jonathan Zaffino and Roger M Singer. View Insider Buying and Selling for Everest Re Group.

RE stock was bought by a variety of institutional investors in the last quarter, including Capital International Investors, Victory Capital Management Inc., AQR Capital Management LLC, Point72 Asset Management L.P., Franklin Resources Inc., Victory Capital Management Inc., Janus Henderson Group PLC and Capital Bank & Trust Co. View Insider Buying and Selling for Everest Re Group.

Shares of RE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RE stock can currently be purchased for approximately $273.23.

Everest Re Group has a market capitalization of $11.14 billion and generates $8.23 billion in revenue each year. The insurance provider earns $1.01 billion in net income (profit) each year or $21.34 on an earnings per share basis. Everest Re Group employs 1,415 workers across the globe.View Additional Information About Everest Re Group.

The official website for Everest Re Group is http://www.everestregroup.com/.

Everest Re Group's mailing address is 141 Front Street, HAMILTON D0, HM 19. The insurance provider can be reached via phone at 441-295-0006 or via email at [email protected]